000 | 01171 a2200337 4500 | ||
---|---|---|---|
005 | 20250513212449.0 | ||
264 | 0 | _c20000602 | |
008 | 200006s 0 0 eng d | ||
022 | _a0007-1048 | ||
024 | 7 |
_a10.1046/j.1365-2141.2000.01901.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaker, P | |
245 | 0 | 0 |
_aAla-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin. _h[electronic resource] |
260 |
_bBritish journal of haematology _cMar 2000 |
||
300 |
_a663 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Comment; Letter | ||
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aFactor IX _xgenetics |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 |
_aWarfarin _xadverse effects |
700 | 1 | _aClarke, K | |
700 | 1 | _aGiangrande, P | |
700 | 1 | _aKeeling, D | |
773 | 0 |
_tBritish journal of haematology _gvol. 108 _gno. 3 _gp. 663 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.2000.01901.x _zAvailable from publisher's website |
999 |
_c10798967 _d10798967 |